Rhythm Pharmaceuticals

Boston,  MA 
United States
  • Booth: 1133


Rhythm is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare genetic disorders of obesity that result from genetic deficiencies within a key pathway that regulates hunger (i.e., the melanocortin-4 receptor pathway). The hallmarks of these disorders are insatiable hunger, known as hyperphagia, and severe, early-onset obesity. By leveraging cutting-edge insights and expertise in precision medicine, Rhythm is dedicated to pioneering groundbreaking therapies for these rare disorders. Learn more about Rhythm's pipeline and its commitment to rare genetic disorders of obesity at www.rhythmtx.com